Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Cardiovascular risk factors in long‐term followup after orthotopic liver transplantation
1997
The Treatment of Chronic Viral Hepatitis
1997
CYTOMEGALOVIRUS VIREMIA
1997
Direct Cell Surface Modification with DNA for the Capture of Primary Cells and the Investigation of Myotube Formation on Defined Patterns
2009 StandoutNobel
Delayed graft function in kidney transplantation
2004 Standout
Pharmacodynamics of immunosuppressive drugs
2000
Cancer in patients on dialysis for end-stage renal disease: an international collaborative study
1999 Standout
A Reversible Posterior Leukoencephalopathy Syndrome
1996 Standout
The Emerging Role of Recombinant-Activated Factor VII in Neurocritical Care
2004
Cancer Metastasis: Building a Framework
2006 Standout
The Compensatory Anti-inflammatory Response Syndrome (CARS) in Critically Ill Patients
2008
Classification of Surgical Complications
2004 Standout
Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients
1999
Circulating Cytomegalovirus (CMV)-Infected Endothelial Cells in Patients with an Active CMV Infection
1993
Central nervous system complications in liver transplant recipients – incidence, timing, and long‐term follow‐up
2000
Quantitation of Immunosuppression by Tacrolimus Using Flow Cytometric Analysis of Interleukin-2 and Interferon-γ Inhibition in CD8− and CD8+ Peripheral Blood T Cells
2001
Class I and Class Ii Major Histocompatibility Complex Antigen Expression on Hepatocytes: A Study in Children With Liver Disease
1990
Time to Detection of Cytomegalovirus (CMV) DNA in Blood Leukocytes Is a Predictor for the Development of CMV Disease in CMV-Seronegative Recipients of Allografts from CMV-Seropositive Donors following Liver Transplantation
1996
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2005 Standout
Chronic Renal Failure after Transplantation of a Nonrenal Organ
2003 Standout
Identification of functional subsets by flow cytometry: Intracellular detection of cytokine expression
1998
CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION
1998
Crohn's disease
2016 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Priming of hepatitis C virus-specific cytotoxic t lymphocytes in mice following portal vein injection of a liver-specific plasmid DNA
2000 StandoutNobel
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
2010 Standout
De novo malignancies after liver transplantation: A major cause of late death
2001
Clinical Pharmacokinetics and Pharmacodynamics of Tacrolimus in Solid Organ Transplantation
2004 Standout
Immunity, Inflammation, and Cancer
2010 Standout
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2008
Prediction of the inhibition of IL-2 production by calcineurin inhibitors
2001
Emerging Biological Principles of Metastasis
2017 Standout
IFNβ-dependent increases in STAT1, STAT2, and IRF9 mediate resistance to viruses and DNA damage
2013 StandoutNobel
Technology Assessment of the Dutch Lung Transplantation Program
1998
Ulcerative colitis
2016 Standout
Derivation of A Risk Index for the Prediction of Massive Blood Transfusion in Liver Transplantation
2006
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
2011 Standout
Tackling the Shortage of Donor Kidneys: How to Use the Best that We Have
2003
TNFR1 Signaling and IFN-γ Signaling Determine whether T Cells Induce Tumor Dormancy or Promote Multistage Carcinogenesis
2008
Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List
2008 Standout
Sarcoidosis
1997 Standout
Strategies to Improve Long-Term Outcomes after Renal Transplantation
2002 Standout
Paradoxical roles of the immune system during cancer development
2006 Standout
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
1997
Primary Biliary Cirrhosis
1996
Helicobacter pyloriInfection
2002 Standout
Pharmacodynamics of T‐cell function for monitoring immunosuppression
2007
The Independent Role of Cytomegalovirus as a Risk Factor for Invasive Fungal Disease in Orthotopic Liver Transplant Recipients
1997
Liver Transplantation
1989
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Reactivation of Latent Human Cytomegalovirus by Allogeneic Stimulation of Blood Cells from Healthy Donors
1997
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Infection in Solid-Organ Transplant Recipients
2007 Standout
Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
1998 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Infection in Organ-Transplant Recipients
1998 Standout
Acute reversible central nervous system toxicity associated with low-dose oral cyclosporine therapy
1993
Antibiotic prophylaxis to reduce respiratory tract infections and mortality in adults receiving intensive care
2004
Prevention and Treatment of Major Blood Loss
2007
Association of multispecific CD4+ response to hepatitis C and severity of recurrence after liver transplantation
1999 StandoutNobel
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Effect of postoperative complications on health and employment following liver transplantation
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Standardized Bleeding Definitions for Cardiovascular Clinical Trials
2011 Standout
The crystal structure of urease from Klebsiella aerogenes
1995 StandoutScience
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Compensatory anti-inflammatory response syndrome
2008
Primary Biliary Cirrhosis
2011 Standout
A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation
1994 Standout
Cancer incidence and risk factors after solid organ transplantation
2009
Pathogenicity of Helicobacter pylori: a perspective
1993
Human Cytomegalovirus Inhibits Cytokine-Induced Macrophage Differentiation
2004
Emergence of DiverseHelicobacterSpecies in the Pathogenesis of Gastric and Enterohepatic Diseases
2001
De Novo Neoplasia After Liver Transplantation: An Analysis of Risk Factors and Influence on Survival
2004
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
2009
Immunobiology of Dendritic Cells
2000 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response
2000 StandoutNobel
European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies
2015
CD8 lymphocytosis in primary cytomegalovirus (CMV) infection of allograft recipients: expansion of an uncommon CD8+ CD57− subset and its progressive replacement by CD8+CD57+ T cells
1994
Synergistic effect of HIF-1α gene therapy and HIF-1-activated bone marrow-derived angiogenic cells in a mouse model of limb ischemia
2009 StandoutNobel
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
2014 Standout
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications
2011
Cytomegalovirus (CMV) antigenemia assay is more sensitive than shell vial cultures for rapid detection of CMV in polymorphonuclear blood leukocytes
1992
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
2013
Works of I. J. Klompmaker being referenced
ASSESSMENT OF THE QUALITY OF LIFE BEFORE AND FOLLOWING LIVER TRANSPLANTATION
1992
REDUCED TRANSFUSION REQUIREMENTS BY RECOMBINANT FACTOR VIIa IN ORTHOTOPIC LIVER TRANSPLANTATION
2001
Increased cancer risk after liver transplantation: a population-based study
2001
LOW HLA-DR EXPRESSION ON MONOCYTES AS A PROGNOSTIC MARKER FOR BACTERIAL SEPSIS AFTER LIVER TRANSPLANTATION
1997
PREDICTION OF RECURRENT CYTOMEGALOVIRUS DISEASE AFTER TREATMENT WITH GANCICLOVIR IN SOLID-ORGAN TRANSPLANT RECIPIENTS
1993
QUANTITATION OF IMMUNOSUPPRESSION BY FLOW CYTOMETRIC MEASUREMENT OF THE CAPACITY OF T CELLS FOR INTERLEUKIN-2 PRODUCTION1
1998
Long-Term Results after Liver Transplantation in Adults
1991
Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients
2000
Splenic artery aneurysms in liver transplant patients
1997
Histological and biochemical effects of cyclosporine A withdrawal from a triple drug regimen after over 2 years of treatment in liver transplant patients
1995
Is there recurrence of primary biliary cirrhosis after liver transplantation?
1994
Selection criteria for liver donation: a review
1993
Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis
1998
Selective decontamination of the digestive tract to prevent postoperative infection: A randomized placebo-controlled trial in liver transplant patients
2002
Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection
1996
Early induction of MHC antigens in human liver grafts. An immunohistologic study.
1988
Antigenemia in the Diagnosis and Monitoring of Active Cytomegalovirus Infection after Liver Transplantation
1991
Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis
1998
Donor data in liver grafts with primary non-function--a preliminary analysis by the European Liver Registry.
1989
Cyclosporine neurotoxicity late after liver transplantation.
1989
Effects of cyclosporin A withdrawal on renal function and renal stimulation in liver transplant patients treated with triple-drug immunosuppression for over 2 years
1994